Women face increased cancer risk - BBC News
One in 10 women in the UK currently develop breast cancer by the age of 80 but researchers fear this may rise to one in seven by 2024 unless changes are made. Around one in 500 people are said to carry the gene mutations which result in an 85-90

Zynx Health Partners with the National Comprehensive Cancer Network - PR Inside
www.zynx.com - Zynx Health Alec Green, 310-954-1978 Director, Business Development and Marketing agreen@zynx.com or NCCN Thomas Mitchell, 215-690-0245 Zynx Health, the leader in evidence-based healthcare, today announced it will partner with the

Market Report — In Play (GSK) - MSN MoneyCentral
GlaxoSmithKline says new data on MAGE-A3 cancer immunotherapy support potential novel options of treating non-small cell lung cancer and melanoma New data presented by GSK highlights the potential of its investigational MAGE-A3 Antigen-Specific

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel - MSN MoneyCentral
CHICAGO, May 30 /PRNewswire-FirstCall/ — New data presented by GlaxoSmithKline (GSK) today highlighted the potential of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) through results of three studies evaluating highly

Type of Tomato Product Determines Power Against Prostate Cancer - KVIA.com
A study in the June 1 issue of Cancer Research finds that the type of tomato product you eat may play a role in whether it can fight prostate cancer. Specifically, an organic carbohydrate known as FruHis, which is produced when tomatoes are

Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast - Forbes
CHICAGO, May 30 /PRNewswire/ — Ipsogen SA (Marseilles, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukaemia announced today that it is entering the breast cancer diagnostic market with the European